Kamada Ltd. (KMDA) DCF Valuation

Kamada Ltd. (KMDA) DCF -Bewertung

IL | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
Kamada Ltd. (KMDA) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Kamada Ltd. (KMDA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Unser (KMDA) DCF-Taschenrechner entwickelt für die Genauigkeit und ermöglicht es Ihnen, die Bewertung der Kamada Ltd. mithilfe von Finanzinformationen in Echtzeit zu bewerten, und bietet vollständige Flexibilität, um wesentliche Parameter für verbesserte Prognosen zu ändern.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 127.2 133.2 103.6 129.3 142.5 148.8 155.3 162.1 169.2 176.6
Revenue Growth, % 0 4.76 -22.22 24.79 10.19 4.38 4.38 4.38 4.38 4.38
EBITDA 27.3 25.4 5.2 4.5 21.5 19.1 19.9 20.8 21.7 22.7
EBITDA, % 21.47 19.07 5.02 3.5 15.11 12.83 12.83 12.83 12.83 12.83
Depreciation 4.7 5.2 5.8 11.6 11.5 9.0 9.4 9.8 10.2 10.7
Depreciation, % 3.67 3.94 5.63 8.97 8.05 6.05 6.05 6.05 6.05 6.05
EBIT 22.6 20.2 -.6 -7.1 10.1 10.1 10.5 11.0 11.5 12.0
EBIT, % 17.8 15.14 -0.60982 -5.47 7.06 6.78 6.78 6.78 6.78 6.78
Total Cash 73.9 109.3 18.6 34.3 55.6 66.5 69.4 72.5 75.7 79.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 25.2 23.5 35.2 27.3 21.3
Account Receivables, % 19.83 17.64 33.93 21.07 14.92
Inventories 43.2 42.0 67.4 68.8 88.5 73.1 76.3 79.7 83.2 86.8
Inventories, % 33.94 31.53 65.05 53.18 62.08 49.16 49.16 49.16 49.16 49.16
Accounts Payable 24.8 16.1 25.1 32.9 24.8 29.4 30.6 32.0 33.4 34.9
Accounts Payable, % 19.52 12.09 24.22 25.45 17.4 19.74 19.74 19.74 19.74 19.74
Capital Expenditure -2.3 -5.5 -3.7 -3.8 -5.9 -4.9 -5.1 -5.4 -5.6 -5.8
Capital Expenditure, % -1.81 -4.12 -3.6 -2.93 -4.1 -3.31 -3.31 -3.31 -3.31 -3.31
Tax Rate, % 1.72 1.72 1.72 1.72 1.72 1.72 1.72 1.72 1.72 1.72
EBITAT 21.9 18.6 -.7 -7.3 9.9 9.8 10.3 10.7 11.2 11.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -19.3 12.5 -26.7 14.9 -6.3 23.1 11.2 11.7 12.2 12.7
WACC, % 5.36 5.34 5.37 5.37 5.36 5.36 5.36 5.36 5.36 5.36
PV UFCF
SUM PV UFCF 61.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 13
Terminal Value 387
Present Terminal Value 298
Enterprise Value 360
Net Debt -47
Equity Value 407
Diluted Shares Outstanding, MM 54
Equity Value Per Share 7.58

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real KMDA financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Kamada Ltd.'s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Kamada Ltd. (KMDA).
  • WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Easily alter growth projections, capital expenditures, and discount rates.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Kamada Ltd. (KMDA).
  • Interactive Dashboard and Charts: Visual representations that summarize essential valuation metrics for straightforward analysis.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Kamada Ltd. (KMDA) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Kamada Ltd.'s (KMDA) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose Kamada Ltd. (KMDA) Calculator?

  • Accuracy: Utilizes real Kamada financials for precise data.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate Kamada Ltd.'s (KMDA) performance before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methods and assess financial forecasts for Kamada Ltd. (KMDA).
  • Startup Founders: Discover the valuation strategies of established companies like Kamada Ltd. (KMDA).
  • Consultants: Provide comprehensive valuation assessments for clients interested in Kamada Ltd. (KMDA).
  • Students and Educators: Utilize current data from Kamada Ltd. (KMDA) to enhance learning on valuation practices.

What the Kamada Ltd. (KMDA) Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations specific to Kamada Ltd.
  • Real-World Data: Kamada Ltd.’s historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into Kamada Ltd.'s performance.
  • Key Ratios: Integrated analysis for assessing profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results tailored to Kamada Ltd. (KMDA).


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.